Impact of HIV infection status on interpretation of quantitative PCR for detection of pneumocystis jirovecii

Journal of Clinical Microbiology

Volumn 53, Issue 12, 2015, Pages 3870-3875

  Louis, M ^a   Guitard, J ^a,b,c   Jodar, M ^a   Ancelle, T ^d   Magne, D ^a   Lascols, O ^a   Hennequin, C ^a,b,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b Assistance publique Hôpitaux de Paris   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FUNGAL COLONIZATION; FUNGAL DETECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PATHOGEN LOAD; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; AGED; BACTERIAL COUNT; BRONCHOALVEOLAR LAVAGE FLUID; COMPLICATION; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMOCYSTIS CARINII; PNEUMONIA, PNEUMOCYSTIS; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CARRIER STATE; COLONY COUNT, MICROBIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PNEUMOCYSTIS CARINII; PNEUMONIA, PNEUMOCYSTIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 84947796190     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02072-15     Document Type: Article

References (33)

1. Thomas CF, Jr, Limper AH. (2004). Pneumocystis pneumonia. N Engl J Med 350: 2487-2498. http://dx.doi.org/10.1056/NEJMra032588
2. Sepkowitz KA. (2002). Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 34: 1098-1107. http://dx.doi.org/10.1086/339548
3. Bollee G, Sarfati C, Thiery G, Bergeron A, De Miranda S, Menotti J, De Castro N, Tazi A, Schlemmer B, Azoulay E. (2007). Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest 132: 1305-1310. http://dx.doi.org/10.1378/chest.07-0223
4. Magne D, Angoulvant A, Botterel F, Bouges-Michel C, Bougnoux ME, Bouree P, Chochillon C, Cornet M, Dannaoui E, Fekkar A, Galeazzi G, Yera H, Sarfati C, Roux P. (2011). Pneumocystosis: a network survey in the Paris area 2003-2008. Eur J Clin Microbiol Infect Dis 30: 673-675. http://dx.doi.org/10.1007/s10096-010-1139-0
5. Schildgen V, Mai S, Khalfaoui S, Lusebrink J, Pieper M, Tillmann RL, Brockmann M, Schildgen O. (2014). Pneumocystis jirovecii can be productively cultured in differentiated CuFi-8 airway cells. mBio 5: e01186-14. http://dx.doi.org/10.1128/mBio.01186-14
6. Tasaka S, Tokuda H. (2013). Recent advances in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected adults. Expert Opin Med Diagn 7: 85-97. http://dx.doi.org/10.1517/17530059.2012.722080
7. Wolfson JS, Waldron MA, Sierra LS. (1990). Blinded comparison of a direct immunofluorescent monoclonal antibody staining method and a Giemsa staining method for identification of Pneumocystis carinii in induced sputum and bronchoalveolar lavage specimens of patients infected with human immunodeficiency virus. J Clin Microbiol 28: 2136-2138
8. Flori P, Bellete B, Durand F, Raberin H, Cazorla C, Hafid J, Lucht F, Sung RT. (2004). Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol 53: 603-607. http://dx.doi.org/10.1099/jmm.0.45528-0
9. Durand-Joly I, Chabe M, Soula F, Delhaes L, Camus D, Dei-Cas E. (2005). Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol Med Microbiol 45: 405-410. http://dx.doi.org/10.1016/j.femsim.2005.06.006
10. Takahashi T, Goto M, Endo T, Nakamura T, Yusa N, Sato N, Iwamoto A. (2002). Pneumocystis carinii carriage in immunocompromised patients with and without human immunodeficiency virus infection. J Med Microbiol 51: 611-614. http://dx.doi.org/10.1099/0022-1317-51-7-611
11. Morris A, Kingsley LA, Groner G, Lebedeva IP, Beard CB, Norris KA. (2004). Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 18: 793-798. http://dx.doi.org/10.1097/00002030-200403260-00011
12. Linssen CF, Jacobs JA, Beckers P, Templeton KE, Bakkers J, Kuijper EJ, Melchers WJ, Drent M, Vink C. (2006). Inter-laboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jiroveci in bronchoalveolar lavage fluid samples. J Med Microbiol 55: 1229-1235. http://dx.doi.org/10.1099/jmm.0.46552-0
13. Matsumura Y, Ito Y, Iinuma Y, Yasuma K, Yamamoto M, Matsushima A, Nagao M, Takakura S, Ichiyama S. (2012). Quantitative real-time PCR and the (13)-beta-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clin Microbiol Infect 18: 591-597. http://dx.doi.org/10.1111/j.1469-0691.2011.03605.x
14. Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, Molina JM, Derouin F, Menotti J. (2011). Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect 17: 1531-1537. http://dx.doi.org/10.1111/j.1469-0691.2010.03400.x
15. Botterel F, Cabaret O, Foulet F, Cordonnier C, Costa JM, Bretagne S. (2012). Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. J Clin Microbiol 50: 227-231. http://dx.doi.org/10.1128/JCM.06036-11
16. Mühlethaler K, Bogli-Stuber K, Wasmer S, von Garnier C, Dumont P, Rauch A, Muhlemann K, Garzoni C. (2012). Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J 39: 971-978. http://dx.doi.org/10.1183/09031936.00095811
17. Chumpitazi BF, Flori P, Kern JB, Brenier-Pinchart MP, Hincky-Vitrat V, Brion JP, Thiebaut-Bertrand A, Minet C, Maubon D, Pelloux H. (2011). Characteristics and clinical relevance of the quantitative touchdown major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia. Med Mycol 49: 704-713. http://dx.doi.org/10.3109/13693786.2011.566894
18. Maillet M, Maubon D, Brion JP, Francois P, Molina L, Stahl JP, Epaulard O, Bosseray A, Pavese P. (2014). Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients. Eur J Clin Microbiol Infect Dis 33: 331-336. http://dx.doi.org/10.1007/s10096-013-1960-3
19. Robert-Gangneux F, Belaz S, Revest M, Tattevin P, Jouneau S, Decaux O, Chevrier S, Le Tulzo Y, Gangneux JP. (2014). Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study. J Clin Microbiol 52: 3370-3376. http://dx.doi.org/10.1128/JCM.01480-14
20. Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala M, Dary M, De Gentile L, Gandji JA, Guimard Y, Lacroix C, Roblot P, Becq-Giraudon B. (2002). Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIVnegative patients. Eur J Clin Microbiol Infect Dis 21: 523-531. http://dx.doi.org/10.1007/s10096-002-0758-5
21. Roux A, Canet E, Valade S, Gangneux-Robert F, Hamane S, Lafabrie A, Maubon D, Debourgogne A, Le Gal S, Dalle F, Leterrier M, Toubas D, Pomares C, Bellanger AP, Bonhomme J, Berry A, Durand-Joly I, Magne D, Pons D, Hennequin C, Maury E, Roux P, Azoulay E. (2014). Pneumocystis jiroveci pneumonia in patients with or without AIDS, France. Emerg Infect Dis 20: 1490-1497. http://dx.doi.org/10.3201/eid2009.131668
22. Boonsarngsuk V, Sirilak S, Kiatboonsri S. (2009). Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors. Int J Infect Dis 13: 59-66. http://dx.doi.org/10.1016/j.ijid.2008.03.027
23. Meliani L, Develoux M, Marteau-Miltgen M, Magne D, Barbu V, Poirot JL, Roux P. (2003). Real time quantitative PCR assay for Pneumocystis jirovecii detection. J Eukaryot Microbiol 50(Suppl): 651. http://dx.doi.org/10.1111/j.1550-7408.2003.tb00670.x
24. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. (2012). Hidden killers: human fungal infections. Sci Transl Med 4: 165rv113. http://dx.doi.org/10.1126/scitranslmed.3004404
25. Fillaux J, Malvy S, Alvarez M, Fabre R, Cassaing S, Marchou B, Linas MD, Berry A. (2008). Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia. J Microbiol Methods 75: 258-261. http://dx.doi.org/10.1016/j.mimet.2008.06.009
26. Cerón I, Rabagliati R, Langhaus J, Silva F, Guzman AM, Lagos M. (2014). Características clínicas, diagnósticas y pronósticas De pacientes con neumonía por Pneumocystis jiroveci en individuos infectados por virus De inmunodeficiencia humana e individuos inmunocomprometidos por otra etiología. Rev Chilena Infectol 31: 417-424. http://dx.doi.org/10.4067/S0716-10182014000400007
27. Morris A, Wei K, Afshar K, Huang L. (2008). Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 197: 10-17. http://dx.doi.org/10.1086/523814
28. Leigh TR, Kangro HO, Gazzard BG, Jeffries DJ, Collins JV. (1993). DNA amplification by the polymerase chain reaction to detect sub-clinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms. Respir Med 87: 525-529. http://dx.doi.org/10.1016/0954-6111(93)90008-N
29. Davis JL, Welsh DA, Beard CB, Jones JL, Lawrence GG, Fox MR, Crothers K, Morris A, Charbonnet D, Swartzman A, Huang L. (2008). Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia. Thorax 63: 329-334. http://dx.doi.org/10.1136/thx.2007.088104
30. Reid AB, Chen SC, Worth LJ. (2011). Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools. Curr Opin Infect Dis 24: 534-544. http://dx.doi.org/10.1097/QCO.0b013e32834cac17
31. Lipschik GY, Gill VJ, Lundgren JD, Andrawis VA, Nelson NA, Nielsen JO, Ognibene FP, Kovacs JA. (1992). Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet 340: 203-206. http://dx.doi.org/10.1016/0140-6736(92)90469-J
32. Desmet S, Van Wijngaerden E, Maertens J, Verhaegen J, Verbeken E, De Munter P, Meersseman W, Van Meensel B, Van Eldere J, Lagrou K. (2009). Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol 47: 3871-3874. http://dx.doi.org/10.1128/JCM.01756-09
33. Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, Takeuchi T, Ishizaka A. (2007). Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 131: 1173-1180. http://dx.doi.org/10.1378/chest.06-1467